6-fluoro-2-(4-(pyridin-2-yl)but-3-yn-1-yl)imidazo(1-2-a)pyridine and mavoglurant

6-fluoro-2-(4-(pyridin-2-yl)but-3-yn-1-yl)imidazo(1-2-a)pyridine has been researched along with mavoglurant* in 1 studies

Other Studies

1 other study(ies) available for 6-fluoro-2-(4-(pyridin-2-yl)but-3-yn-1-yl)imidazo(1-2-a)pyridine and mavoglurant

ArticleYear
Understanding Exposure-Receptor Occupancy Relationships for Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators across a Range of Preclinical and Clinical Studies.
    The Journal of pharmacology and experimental therapeutics, 2021, Volume: 377, Issue:1

    The metabotropic glutamate receptor 5 (mGlu

    Topics: Administration, Oral; Allosteric Regulation; Allosteric Site; Animals; Brain; Clinical Studies as Topic; Dose-Response Relationship, Drug; Excitatory Amino Acid Agents; Imidazoles; Indoles; Macaca fascicularis; Male; Mice; Mice, Inbred C57BL; Protein Binding; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5

2021